A managing director in Newmark Knight Frank’s Boston office, Brendan Daly is a member of a four-person team specializing in the Route 128 West and laboratory markets. Mr. Daly joined the company in 2015 after working at Cushman & Wakefield and NAI Hunneman, where he focused on tenant and landlord advisory assignments.
Throughout his career, Mr. Daly has successfully represented some of the region’s most notable corporations within the technology and biotech industries, ranging from global firms including iBasis, Integra Lifesciences, Texas Instruments and VM Ware to early and mid-stage companies including Everbridge, Ipswitch, Nano Terra and lifeIMAGE. He has also successfully represented many of suburban Boston’s most active owners and developers, including Alexandria Real Estate Equities, Boston Properties, Davis Companies, Duffy Properties, Nordblom Company and Saracen Properties.
Mr. Daly is a graduate of the University of Dayton and currently resides in Charlestown. He is an active member of the Commercial Brokers Association and has participated in charitable work for the ALS Therapy Development Institute and AmpSurf.